Literature DB >> 2441080

The avian influenza virus nucleoprotein gene and a specific constellation of avian and human virus polymerase genes each specify attenuation of avian-human influenza A/Pintail/79 reassortant viruses for monkeys.

M H Snyder, A J Buckler-White, W T London, E L Tierney, B R Murphy.   

Abstract

Reassortant viruses which possessed the hemagglutinin and neuraminidase genes of wild-type human influenza A viruses and the remaining six RNA segments (internal genes) of the avian A/Pintail/Alberta/119/79 (H4N6) virus were previously found to be attenuated in humans. To study the genetic basis of this attenuation, we isolated influenza A/Pintail/79 X A/Washington/897/80 reassortant viruses which contained human influenza virus H3N2 surface glycoprotein genes and various combinations of avian or human influenza virus internal genes. Twenty-four reassortant viruses were isolated and first evaluated for infectivity in avian (primary chick kidney [PCK]) and mammalian (Madin-Darby canine kidney [MDCK]) tissue culture lines. Reassortant viruses with two specific constellations of viral polymerase genes exhibited a significant host range restriction of replication in mammalian (MDCK) tissue culture compared with that in avian (PCK) tissue culture. The viral polymerase genotype PB2-avian (A) virus, PB1-A virus, and PA-human (H) virus was associated with a 900-fold restriction, while the viral polymerase genotype PB2-H, PB1-A, and PA-H was associated with an 80,000-fold restriction of replication in MDCK compared with that in PCK. Fifteen reassortant viruses were subsequently evaluated for their level of replication in the respiratory tract of squirrel monkeys, and two genetic determinants of attenuation were identified. First, reassortant viruses which possessed the avian influenza virus nucleoprotein gene were as restricted in replication as a virus which possessed all six internal genes of the avian influenza A virus parent, indicating that the nucleoprotein gene is the major determinant of attenuation of avian-human A/Pintail/79 reassortant viruses for monkeys. Second, reassortant viruses which possessed the viral polymerase gene constellation of PB2-H, PB1-A, and PA-H, which was associated with the greater degree of host range restriction in vitro, were highly restricted in replication in monkeys. Since the avian-human influenza reassortant viruses which expressed either mode of attenuation in monkeys replicated to high titer in eggs and in PCK tissue culture, their failure to replicate efficiently in the respiratory epithelium of primates must be due to the failure of viral factors to interact with primate host cell factors. The implications of these findings for the development of live-virus vaccines and for the evolution of influenza A viruses in nature are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2441080      PMCID: PMC255805     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  A highly sensitive technique for staining DNA and RNA in polyacrylamide gels using silver.

Authors:  T Boulikas; R Hancock
Journal:  J Biochem Biophys Methods       Date:  1981-10

2.  Temperature-sensitive mutants of influenza A/Udorn/72 (H3N2) virus. I. Isolation of temperature-sensitive mutants some of which exhibit host-dependent temperature sensitivity.

Authors:  K Shimizu; M G Mullinix; R M Chanock; B R Murphy
Journal:  Virology       Date:  1982-02       Impact factor: 3.616

3.  Host range mutants of an influenza A virus.

Authors:  C Scholtissek; B R Murphy
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

4.  On the origin of the human influenza virus subtypes H2N2 and H3N2.

Authors:  C Scholtissek; W Rohde; V Von Hoyningen; R Rott
Journal:  Virology       Date:  1978-06-01       Impact factor: 3.616

5.  Role of two of the influenza virus core P proteins in recognizing cap 1 structures (m7GpppNm) on RNAs and in initiating viral RNA transcription.

Authors:  I Ulmanen; B A Broni; R M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

6.  Temperature-sensitive mutants of influenza A/Udorn/72 (H3N2) virus. III. Genetic analysis of temperature-dependent host range mutants.

Authors:  K Shimizu; M G Mullinix; R M Chanock; B R Murphy
Journal:  Virology       Date:  1983-01-15       Impact factor: 3.616

7.  Evolution of the nucleotide sequence of influenza virus RNA segment 7 during drift of the H3N2 subtype.

Authors:  J Ortín; C Martínez; L del Río; M Dávila; C López-Galíndez; N Villanueva; E Domingo
Journal:  Gene       Date:  1983-08       Impact factor: 3.688

8.  Reassortant virus derived from avian and human influenza A viruses is attenuated and immunogenic in monkeys.

Authors:  B R Murphy; D L Sly; E L Tierney; N T Hosier; J G Massicot; W T London; R M Chanock; R G Webster; V S Hinshaw
Journal:  Science       Date:  1982-12-24       Impact factor: 47.728

9.  A temperature-dependent host range mutant of fowl plague virus (FPV).

Authors:  A Israël
Journal:  Virology       Date:  1980-08       Impact factor: 3.616

10.  Virulence of avian influenza A viruses for squirrel monkeys.

Authors:  B R Murphy; V S Hinshaw; D L Sly; W T London; N T Hosier; F T Wood; R G Webster; R M Chanock
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

View more
  61 in total

1.  Sialic acid species as a determinant of the host range of influenza A viruses.

Authors:  Y Suzuki; T Ito; T Suzuki; R E Holland; T M Chambers; M Kiso; H Ishida; Y Kawaoka
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Seasonal H3N2 and 2009 Pandemic H1N1 Influenza A Viruses Reassort Efficiently but Produce Attenuated Progeny.

Authors:  Kara L Phipps; Nicolle Marshall; Hui Tao; Shamika Danzy; Nina Onuoha; John Steel; Anice C Lowen
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

3.  NP, PB1, and PB2 viral genes contribute to altered replication of H5N1 avian influenza viruses in chickens.

Authors:  Jamie L Wasilenko; Chang Won Lee; Luciana Sarmento; Erica Spackman; Darrell R Kapczynski; David L Suarez; Mary J Pantin-Jackwood
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

4.  Nuclear factor 90 negatively regulates influenza virus replication by interacting with viral nucleoprotein.

Authors:  Pui Wang; Wenjun Song; Bobo Wing-Yee Mok; Pengxi Zhao; Kun Qin; Alexander Lai; Gavin J D Smith; Jinxia Zhang; Tianwei Lin; Yi Guan; Honglin Chen
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

5.  Neuroattenuation of an avirulent bunyavirus variant maps to the L RNA segment.

Authors:  M J Endres; C Griot; F Gonzalez-Scarano; N Nathanson
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

6.  Evolution of an avian H5N1 influenza A virus escape mutant.

Authors:  Kamel M A Hassanin; Ahmed S Abdel-Moneim
Journal:  World J Virol       Date:  2013-11-12

7.  Biochemical impact of the host adaptation-associated PB2 E627K mutation on the temperature-dependent RNA synthesis kinetics of influenza A virus polymerase complex.

Authors:  Shilpa Aggarwal; Stephen Dewhurst; Toru Takimoto; Baek Kim
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

Review 8.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

Review 9.  Cross-species virus transmission and the emergence of new epidemic diseases.

Authors:  Colin R Parrish; Edward C Holmes; David M Morens; Eun-Chung Park; Donald S Burke; Charles H Calisher; Catherine A Laughlin; Linda J Saif; Peter Daszak
Journal:  Microbiol Mol Biol Rev       Date:  2008-09       Impact factor: 11.056

10.  Acquisition of a polybasic hemagglutinin cleavage site by a low-pathogenic avian influenza virus is not sufficient for immediate transformation into a highly pathogenic strain.

Authors:  Olga Stech; Jutta Veits; Siegfried Weber; Daniela Deckers; Diana Schröer; Thomas W Vahlenkamp; Angele Breithaupt; Jens Teifke; Thomas C Mettenleiter; Jürgen Stech
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.